GlobalData05.01.20
North America’s medical devices industry saw a drop of 8.2 percent in overall deal activity during the fourth quarter of 2019, when compared to the four-quarter average, according to GlobalData’s deals database.
A total of 235 deals worth $4.34 billion were announced for the region during the fourth quarter 2019, against the last four-quarter average of 256 deals.
Of all the deal types, venture financing saw most activity in Q4 2019 with 180, representing a 76.6 percent share for the region.
In second place was mergers and acquisitions with 44 deals, followed by private equity deals with 11 transactions, respectively capturing an 18.7 percent and 4.7 percent share of the overall deal activity for the three-month period ended Dec. 31, 2019.
In terms of value of deals, venture financing was the leading category in North America’s medical devices industry with $1.89 billion, while M&A and private equity deals totalled $1.44 billion and $1.01 billion, respectively.
The top five medical devices deals accounted for 43.3 percent of the overall value during the fourth quarter of 2019.
The combined value of the top five medical devices deals stood at $1.88 billion, against the overall value of $4.34 billion recorded for the quarter.
The top five medical devices industry deals of Q4 2019 tracked by GlobalData were:
A total of 235 deals worth $4.34 billion were announced for the region during the fourth quarter 2019, against the last four-quarter average of 256 deals.
Of all the deal types, venture financing saw most activity in Q4 2019 with 180, representing a 76.6 percent share for the region.
In second place was mergers and acquisitions with 44 deals, followed by private equity deals with 11 transactions, respectively capturing an 18.7 percent and 4.7 percent share of the overall deal activity for the three-month period ended Dec. 31, 2019.
In terms of value of deals, venture financing was the leading category in North America’s medical devices industry with $1.89 billion, while M&A and private equity deals totalled $1.44 billion and $1.01 billion, respectively.
The top five medical devices deals accounted for 43.3 percent of the overall value during the fourth quarter of 2019.
The combined value of the top five medical devices deals stood at $1.88 billion, against the overall value of $4.34 billion recorded for the quarter.
The top five medical devices industry deals of Q4 2019 tracked by GlobalData were:
- Altaris Capital Partners’s $650 million private equity deal with 3M
- The $525 million acquisition of Clinical Innovations by Laborie Medical Technologies
- Boston Scientific’s $275 million acquisition of Channel Medsystems
- The $221.34 million acquisition of AvKare by Amneal Pharmaceuticals
- Clayton, Dubilier & Rice’s private equity deal with Cynosure for $205 million.